MERCK Kommanditgesellschaft auf Aktien

MERCK Kommanditgesellschaft auf Aktien, headquartered in Germany and operating in Pharmaceutical Preparation Manufacturing, has set ambitious climate targets.

As of 2025, MERCK KGaA projects its Scope 1 emissions to be about 658 million kg CO2e, Scope 2 emissions to be about 197.07 million kg CO2e (market-based), and Scope 3 emissions to be approximately 3.896 billion kg CO2e. In 2024, the company's reported Scope 1 emissions were around 858.053 million kg CO2e, Scope 2 market-based emissions were about 227.07 million kg CO2e, and Scope 3 emissions were approximately 4.483 billion kg CO2e. For 2020, MERCK KGaA reported Scope 1 emissions of approximately 1.827 billion kg CO2e, Scope 2 emissions of around 324.698 million kg CO2e (market-based), and Scope 3 emissions of about 5.105 billion kg CO2e.

MERCK KGaA is committed to reducing its absolute Scope 1 and Scope 2 greenhouse gas emissions by 50% by 2030, using a 2020 baseline. The company also aims to reduce its Scope 3 emissions by 52% per euro value added by 2030, also with a 2020 baseline. These near-term Science Based Targets (SBTi) are classified as consistent with a 1.5°C warming scenario. Furthermore, MERCK KGaA intends to achieve climate-neutral operations along its entire value chain (covering Scope 1, 2, and 3 emissions) by 2040.